Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 22, 2010

CD56 Expression and Poor Outcome in AIDA-Treated APL

Blood

 

Additional Info

Blood
Clinical Significance of CD56 Expression in Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid and Anthracycline-Based Regimens
Blood 2010 Dec 08;[EPub Ahead of Print], P Montesinos, C Rayón, E Vellenga, S Brunet, J González, M González, A Holowiecka, J Esteve, J Bergua, JD González, C Rivas, M Tormo, V Rubio, J Bueno, F Manso, G Milone, J de la Serna, I Pérez, M Pérez-Encinas, I Krsnik, JM Ribera, L Escoda, B Lowen

Further Reading